JNK India Q1FY27 EBITDA Surges 3.1x to ₹21.9 Cr, Income Jumps 80.6%
JNK India reported a strong Q1FY27 with total income up 80.6% YoY to ₹186.0 Cr. EBITDA surged 3.1x to ₹21.9 Cr, and PAT grew 8.5x to ₹9.6 Cr. The order book stands at ₹1,801 Cr, with a ₹6,000 Cr bidding pipeline. The company is diversifying into renewable energy and other sectors.
The significant increase in revenue, EBITDA, and PAT, coupled with a robust order pipeline and strategic expansion into new growth areas like renewable energy, suggests a material positive impact on the company's financial health and market position.
The company reported substantial year-on-year growth in key financial metrics like total income, EBITDA, and PAT, along with a strong order book and strategic diversification plans, indicating positive business performance and future outlook.
JNK India Limited announced its unaudited consolidated financial results for the quarter ended June 30, 2026, reporting a strong start to FY27.
Total income grew by approximately 80.6% year-on-year to ₹186.0 crore in Q1FY27, compared to ₹103.0 crore in Q1FY26. EBITDA (including other income) saw a significant increase of 3.1 times, reaching ₹21.9 crore from ₹7.2 crore in the prior year's comparable quarter. The EBITDA margin was maintained at a healthy 11.8% in Q1FY27, up from 7.0% in Q1FY26. Profit After Tax (PAT) also surged by 8.5 times to ₹9.6 crore from ₹1.1 crore year-on-year, with a PAT margin of 5.2% compared to 1.1% in Q1FY26.
The company's order book stood at ₹1,801 crore as of June 30, 2026, with a bidding pipeline of approximately ₹6,000 crore across domestic and international markets. JNK India is also diversifying its business into new and adjacent opportunities, including off-shore, metals & minerals, and renewable energy, with its subsidiary JNK Chemdist actively involved in green hydrogen projects. The company aims to leverage its existing capabilities into new growth opportunities, focusing on strong execution and converting its pipeline into new orders.
Total income for Q1FY27 includes revenue of ₹16.5 crore from JNK Chemdist Limited, which was not part of the previous year's Q1 results.
What to do with a filing like this
JNK India Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by JNK India Limited. Read the original for the full detail.